AstraZeneca Pharma India (506820) Q2 26/27 earnings summary

Executive summary

• Q2 FY27 revenue from operations was Rs 7,291.0 million; profit after tax was Rs 623.3 million, including exceptional expenses of Rs 149.6 million.

• H1 FY27 revenue was Rs 14,118.9 million and profit after tax was Rs 1,002.6 million; operating cash flow was Rs 2,323.8 million.

Financial highlights

• Q2 revenue from operations Rs 7,291.0 million vs Rs 5,590.9 million YoY; total income Rs 7,442.2 million vs Rs 5,652.6 million.

• Q2 profit before exceptional items and tax Rs 1,034.5 million vs Rs 781.1 million YoY; profit after tax Rs 623.3 million vs Rs 542.2 million.

• H1 revenue from operations Rs 14,118.9 million vs Rs 10,854.0 million; profit before exceptional items and tax Rs 1,544.4 million vs Rs 1,531.7 million.

• H1 profit after tax Rs 1,002.6 million vs Rs 1,100.5 million; basic and diluted EPS Rs 40.10 vs Rs 44.02.

• Q2 basic and diluted EPS Rs 24.93 vs Rs 21.69 YoY; exceptional expenses were Rs 149.6 million, versus Rs 52.9 million YoY.

Segment performance

• Healthcare was identified as the sole reportable segment.